Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly Announces Diabetes Research Partnership with University of Surrey

[PR Newswire] – INDIANAPOLIS, Dec. 22, 2014 /PRNewswire/ — Eli Lilly and Company (LLY) today announced a five-year research partnership with the University of Surrey to study health outcomes, focusing on the effects . . . → Read More: Company Update: Eli Lilly & Company (NYSE:LLY) – Lilly Announces Diabetes Research Partnership with University of Surrey Similar Articles: Market Update (NYSE:LLY): New type 2 diabetes treatment Jardiance® (empagliflozin) tablets for adults now available in U.S. pharmacies Company Update (NYSE:LLY): Type 2 diabetes: Jentadueto® (linagliptin and metformin hydrochloride) tablets label updated to include new data on blood glucose reductions in treatment-naive adults with high baseline A1C Eli Lilly & Company (NYSE:LLY) | Lilly for Better Health™ expands website’s non-product-branded health education resources, focuses on healthy behavior skills